Skip to main navigation Skip to search Skip to main content

In COPD, prophylactic macrolides, but not tetracyclines or quinolones, reduce exacerbations, with fewer serious adverse events

Research output: Contribution to journal › Comment/debate › peer-review

1   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'In COPD, prophylactic macrolides, but not tetracyclines or quinolones, reduce exacerbations, with fewer serious adverse events'. Together they form a unique fingerprint.
Sort by

Nursing and Health Professions

Pharmacology, Toxicology and Pharmaceutical Science